Joshua Dennerlein
Stock Analyst at B of A Securities
(2.17)
# 2,762
Out of 4,761 analysts
89
Total ratings
44.26%
Success rate
-4.76%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WELL Welltower | Maintains: Buy | $221 → $242 | $148.58 | +62.88% | 7 | Feb 18, 2025 | |
SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $126.07 | -9.57% | 2 | Nov 12, 2024 | |
FVR FrontView REIT | Initiates: Buy | $22 | $17.27 | +27.39% | 1 | Oct 28, 2024 | |
GTY Getty Realty | Upgrades: Buy | $31 → $34 | $30.40 | +11.84% | 3 | Oct 21, 2024 | |
AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $27.31 | +13.51% | 2 | Sep 24, 2024 | |
NHI National Health Investors | Initiates: Buy | $92 | $68.96 | +33.41% | 1 | Sep 24, 2024 | |
ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $294.74 | +8.91% | 3 | Sep 24, 2024 | |
LINE Lineage | Initiates: Buy | $100 | $53.88 | +85.60% | 1 | Aug 19, 2024 | |
CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $119.89 | +22.61% | 4 | Aug 12, 2024 | |
MAA Mid-America Apartment Communities | Upgrades: Buy | $144 → $189 | $160.67 | +17.63% | 3 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $49.43 | -19.08% | 4 | May 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $19.74 | +26.65% | 2 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $35.70 | -13.17% | 11 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $66.08 | -19.79% | 9 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $8.89 | -32.51% | 1 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $42.83 | -22.95% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $14.31 | +4.82% | 2 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $57.09 | -8.92% | 1 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $15.89 | - | 4 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $61.64 | -12.39% | 4 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.87 | +64.27% | 9 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $10.42 | +159.12% | 1 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $22.09 | +51.65% | 5 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.88 | - | 4 | Aug 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $72.83 | +7.10% | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $41.38 | +13.58% | 2 | Jan 20, 2022 |
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $148.58
Upside: +62.88%
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $126.07
Upside: -9.57%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $17.27
Upside: +27.39%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $30.40
Upside: +11.84%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $27.31
Upside: +13.51%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $68.96
Upside: +33.41%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $294.74
Upside: +8.91%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $53.88
Upside: +85.60%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $119.89
Upside: +22.61%
Mid-America Apartment Communities
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $160.67
Upside: +17.63%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $49.43
Upside: -19.08%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $19.74
Upside: +26.65%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $35.70
Upside: -13.17%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $66.08
Upside: -19.79%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $8.89
Upside: -32.51%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $42.83
Upside: -22.95%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $14.31
Upside: +4.82%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $57.09
Upside: -8.92%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $15.89
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $61.64
Upside: -12.39%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.87
Upside: +64.27%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $10.42
Upside: +159.12%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $22.09
Upside: +51.65%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.88
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $72.83
Upside: +7.10%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $41.38
Upside: +13.58%